PT1315515E - Utilização de eritropoietina, bem como dos seus derivados, para o tratamento de esquizofrenia e psicoses relacionadas - Google Patents

Utilização de eritropoietina, bem como dos seus derivados, para o tratamento de esquizofrenia e psicoses relacionadas Download PDF

Info

Publication number
PT1315515E
PT1315515E PT01982244T PT01982244T PT1315515E PT 1315515 E PT1315515 E PT 1315515E PT 01982244 T PT01982244 T PT 01982244T PT 01982244 T PT01982244 T PT 01982244T PT 1315515 E PT1315515 E PT 1315515E
Authority
PT
Portugal
Prior art keywords
erythropoietin
treating
related psychoses
psychoses
derivatives
Prior art date
Application number
PT01982244T
Other languages
English (en)
Inventor
Hannelore Ehrenreich
Original Assignee
Hannelore Ehrenreich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hannelore Ehrenreich filed Critical Hannelore Ehrenreich
Publication of PT1315515E publication Critical patent/PT1315515E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PT01982244T 2000-09-04 2001-09-04 Utilização de eritropoietina, bem como dos seus derivados, para o tratamento de esquizofrenia e psicoses relacionadas PT1315515E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10043457A DE10043457A1 (de) 2000-09-04 2000-09-04 Verfahren zur Behandlung von Schizophrenie und verwandten Psychosen sowie Verwendung von Erythropoietin oder Erythropoietinderivaten zur Behandlung von Schizophrenien und verwandten Psychosen

Publications (1)

Publication Number Publication Date
PT1315515E true PT1315515E (pt) 2008-03-03

Family

ID=7654867

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01982244T PT1315515E (pt) 2000-09-04 2001-09-04 Utilização de eritropoietina, bem como dos seus derivados, para o tratamento de esquizofrenia e psicoses relacionadas

Country Status (10)

Country Link
US (1) US20040009912A1 (pt)
EP (1) EP1315515B1 (pt)
JP (1) JP2004522696A (pt)
AU (1) AU2002213878A1 (pt)
CY (1) CY1107287T1 (pt)
DE (2) DE10043457A1 (pt)
DK (1) DK1315515T3 (pt)
ES (1) ES2296819T3 (pt)
PT (1) PT1315515E (pt)
WO (1) WO2002020031A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1736481A1 (en) 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Erythropoietin variants
US9988427B2 (en) 2005-05-13 2018-06-05 Charite Universitaetsmedizen-Berlin Erythropoietin variants
US20070072795A1 (en) * 2005-09-28 2007-03-29 Anton Haselbeck Treatment of neurodegenerative disorders
RU2484836C2 (ru) * 2011-09-21 2013-06-20 Александр Иванович Воронов Способ лечения шизофрении

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
JP3156236B2 (ja) * 1991-09-30 2001-04-16 雪印乳業株式会社 記憶障害改善治療剤
DE19857609A1 (de) * 1998-12-14 2000-06-15 Hannelore Ehrenreich Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
CZ20013695A3 (cs) * 1999-04-13 2002-02-13 Kenneth S. Warren Laboratories Farmaceutický prostředek

Also Published As

Publication number Publication date
US20040009912A1 (en) 2004-01-15
WO2002020031A3 (de) 2002-08-01
EP1315515B1 (de) 2007-11-21
CY1107287T1 (el) 2012-11-21
DK1315515T3 (da) 2008-04-14
ES2296819T3 (es) 2008-05-01
WO2002020031A2 (de) 2002-03-14
JP2004522696A (ja) 2004-07-29
DE50113300D1 (de) 2008-01-03
AU2002213878A1 (en) 2002-03-22
DE10043457A1 (de) 2002-03-28
EP1315515A2 (de) 2003-06-04

Similar Documents

Publication Publication Date Title
AU1917302A (en) Diphenyl azetidinone derivatives, method for the production thereof, medicamentscontaining these compounds, and their use
HK1081193A1 (en) Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
EP1414464A4 (en) METHOD OF TREATING GLAUCOMA
PL371192A1 (en) Polymer derivatives for treating metals
IL141388A0 (en) 4-amino substituted-2- substituted 1,2,3,4- tetrahydroquinolines as cetp inhibitors
PL368556A1 (en) Methods for treating or preventing skin disorders using cd2-binding agents
HUP0302739A3 (en) Method for the treatment of tobacco
AU2003249181A1 (en) Methods for treating or preventing ischemic injury
HUP0401760A3 (en) Stent, process for production thereof and its use for treating for restenosen and/or trombozen
EP1450820A4 (en) METHOD OF TREATING AND PREVENTING INFLAMMATORY DISEASES
IL163993A0 (en) Method for treating cognitive disorders
IL157588A0 (en) Carbamate compounds for use in preventing or treating psychotic disorders
AU8333701A (en) Method of treating angiogenesis-related disorders
PT1315515E (pt) Utilização de eritropoietina, bem como dos seus derivados, para o tratamento de esquizofrenia e psicoses relacionadas
AU2002320352A1 (en) Methods for treating or preventing sclerotic disorders using cd2-binding agents
AU3757300A (en) Method of treating anxiety disorders
PL376932A1 (pl) Sposób traktowania żużla
HK1050185A1 (en) Disulfide derivatives useful for treating allergicdiseases
AU7400401A (en) Method for the production of 2- coumarone and substituted 2-coumarones
HUP0301141A3 (en) Method for the production of trioxime derivatives
AU2002243920A1 (en) Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
AU2001236909A1 (en) Method of treating disorders of the eye
EP1401351A4 (en) METHOD OF TREATING GLAUCOMA
AU2002333670A1 (en) Method for treating skin disorders
AU2002258970A1 (en) Method for treating iron based parts